Clinical trial
Safety of EVG+RTV Administered With Other Antiretroviral Agents for the…
NCT00445146 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00445146 |
|---|---|
| Title | Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection |
| Official title | A Phase 2, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | EVG, RTV, ARV regimen |
| Enrollment | 192 |
| Start date | Feb 1, 2007 |
| Primary completion | Mar 1, 2015 |
| Completion | Mar 1, 2015 |
| First posted | Mar 8, 2007 |
| Last update posted | Apr 25, 2016 |
| Countries | Puerto Rico, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: